Patents Assigned to Biolex Newco I, Inc.
  • Patent number: 7022309
    Abstract: Targeting molecules are provided for use in delivering imaging agents to epithelial tissue. The targeting molecule comprises a polypeptide that forms a closed covalent loop, contains at least three peptide domains having ?-sheet character, each of the domains being separated by domains lacking ?-sheet character. The targeting molecule specifically binds to a basolateral factor attached to a basolateral domain of an epithelial cell surface causing internalization of a linked imaging agent into the cells. The polypeptide or imaging agent may be linked to a peptide amino acid sequence that directs delivery of the imaging agent to a carcinoma cell, a nucleus, or an endoplasmic reticulum.
    Type: Grant
    Filed: February 5, 2002
    Date of Patent: April 4, 2006
    Assignee: Biolex Newco I, Inc.
    Inventors: Andrew C. Hiatt, Mich B. Hein, John H. Fitchen